La voie Hippo, découverte chez la Drosophile et conservée chez les mammifères, a été identifiée comme un élément essentiel dans le contrôle de la taille des organes. Cette cascade de kinases régule la phosphorylation de l’effecteur terminal YAP (ou de son paralogue TAZ), un coactivateur transcriptionnel reconnu comme oncogène. Sa fonction est médiée par sa translocation nucléaire et son interaction avec les facteurs de transcription TEAD, pour former le complexe YAP-TEAD qui active l’expression des gènes cibles responsable de la prolifération cellulaire et de la croissance des organes. La surexpression des protéines YAP/TAZ/TEAD dans de nombreux cancers perturbe l’équilibre de la voie Hippo et favorise la formation du complexe protéique causant une hyperprolifération et la propagation des cellules cancéreuses. Inhiber cette interaction protéine-protéine est une cible thérapeutique prometteuse pour concevoir de nouveaux anticancéreux. Dans cette optique, le laboratoire a considéré deux stratégies. La première consiste à cibler la protéine YAP en synthétisant des dipyrrines, représentant des fragments de la Vertéporfine dans le but de définir le motif minimal requis pour conserver l’activité biologique. Une seconde approche implique la synthèse de ligands de TEAD capable de se positionner au sein de l’interface 3. Basée sur des études de modélisation moléculaire, une famille avec un noyau central triazolique a été optimisée pour établir des relations structure-activité. Les molécules synthétisées sont actuellement en cours d’évaluation, grâce à la mise au point des tests biologiques et physicochimiques, et les premiers résultats ont permis d’identifier un composé prometteur. / The Hippo pathway, firstly described in Drosophila and highly conserved in mammals, has been demonstrated to play a crucial role in the organ size control. This kinase cascade regulates the phosphorylation of the downstream effector YAP (or its paralogue TAZ), a transcriptional coactivator with oncogenic activity. Its function is mediated by its nuclear translocation and interaction with the transcriptional factor TEAD, to form YAP-TEAD complex which activates the genes expression in charge of cell proliferation triggering organ growth. Overexpression of YAP/TAZ/TEAD protein in several cancers disrupts the Hippo pathway balance and urges on YAP-TEAD complex formation causing excessive proliferation and cancer development. Inhibiting this protein-protein interaction is thus a promising therapeutic target for the design of new anti-cancer drugs. In this goal, the laboratory has considered two strategies. The first one consists in targeting the YAP protein by synthesizing dipyrrins, representing Verteporfin fragments to define the minimal requirement yielding the expected biological activity. A second approach involves synthesizing TEAD ligands able to fit in specific interface 3. Based on molecular modeling, a triazole scaffold family was optimized to establish structure-activity relationship. Thanks to the biological and binding tests development, synthesized molecules evaluation is still in progress and the present first results have already allowed identifying a promising compound.

Les protéines Vestigial-like constituent une famille de cofacteurs de transcription contenant un domaine très conservé, appelé Tondu, qui permet l’interaction avec les facteurs de transcription de la famille TEAD. L’état de l’art des connaissances actuelles sur cette famille, en termes de répertoire, de structure et de fonction des gènes dans les différents groupes d’animaux, a fait l’objet d’une revue. Durant la thèse, a été étudiée la fonction de deux gènes vestigial, vestigial-like 3 et vestigial-like 4, dans le modèle amphibien xénope. Ce choix découle d’une part, des travaux antérieurs de notre laboratoire qui a caractérisé la famille des gènes vestigial chez le xénope et d’autre part des avantages de ce modèle expérimental qui permet les analyses cellulaires et moléculaires. Les approches de gain et perte de fonction indiquent que vestigial-like 3 est plus particulièrement impliqué dans la migration des cellules de la crête neurale. Vestigial-like 4 a un rôle dans la neurogenèse précoce et la formation de la crête neurale. / Vestigial-like proteins belong to a transcription co factors family with a conserved domain, called tondu, which allows their interaction with TEAD family transcription factors. The state of the art on the current knowledge about this family in terms of gene repertory, structure and functions in different animals has given rise to a review. PhD work has focused on vestigial-like 3 and vestigial-like 4 genes functions in the Xenopus amphibian. This choice stemmed from the laboratory previous works that has described vestigial like gene family in Xenopus, and from the Xenopus model advantages that allows cellular and molecular analysis. Gain and loss of function approaches indicate that vestigial-like 3 is especially implicated in neural crest cells migration. Vestigial-like 4 plays a role in early neurogenesis and neural crest formation.

The Hippo signalling pathway is an evolutionarily conserved kinase cascade responsible for the cell proliferation, tissue growth and apoptosis during development and its dysregulation contributes to tumourigenesis. This signalling pathway was initially discovered in Drosophila and soon after that, it was shown to be highly conserved in mammals. The core Lats kinases of this tumour suppressive pathway phosphorylate and inhibit the downstream transcriptional co-activators YAP and TAZ, which are implicated in various cancers. Latest reports revealed various E3 ubiquitin ligases to negatively regulate the Hippo pathway through ubiquitination, yet few deubiquitinating enzymes have been described. In the present study, we report USP9X deubiquitinating enzyme as an essential regulator of the central components of this pathway. USP9X interacted strongly with Lats2 kinase and to a lesser extent with WW45, Kibra and Angiomotin family proteins. The knockdown of USP9X resulted in notable downregulation and destabilisation of Lats kinase and to lesser extents WW45, Kibra and Amot. This resulted in enhanced nuclear localisation of YAP and TAZ accompanied with activation of their target genes, CTGF and CYR61. USP9X was shown to stabilise Hippo components through its deubiquitinating activity. USP9X enzyme defective mutant lost the activity to stabilise Lats2, WW45, Kibra and Angiomotins through deubiquitination, leading to their ubiquitination. In the absence of USP9X, cells exhibited epithelial to mesenchymal transition phenotype and additionally gained anchorage-independent growth in soft agar. Moreover, USP9X knockdown disrupted acinar organisation of breast cells in three-dimensional acini cultures. In addition, YAP/TAZ target gene activation in USP9X knockdown cells could be rescued by knockdown of YAP, TAZ and TEAD2. Lastly, USP9X protein expression showed a positive correlation with Lats kinases, but negative correlation with YAP/TAZ in pancreatic cancer tissues as well as pancreatic and breast cancer cell lines. The results strongly indicate that USP9X cooperates with Lats2 and other important Hippo components to suppress tumour growth.

The Hippo tumor suppressor pathway is a highly conserved signaling pathway that regulates cell proliferation, differentiation, and organ size. Activation of the Hippo pathway leads to the phosphorylation and cytoplasmic sequestration of the pro-growth transcriptional co-activators YAP/TAZ; by contrast, impairment of the Hippo pathway enables YAP/TAZ to enter the nucleus where they bind to the TEAD transcription factors and induce the expression of genes involved in cell proliferation. Functional impairment of the Hippo pathway, and subsequent hyperactivation of YAP/TAZ, is common in many human malignancies, including melanoma. Recently, small molecule inhibitors that disrupt YAP/TAZ-TEAD binding, and thus reduce oncogenic transcriptional signaling have been discovered, but their efficacy in preventing cancer cell growth has not yet been well characterized. Moreover, no simple biomarker has been identified that can predict sensitivity to such inhibitors. We hypothesized that cells in which YAP/TAZ are enriched in the nucleus relative to the cytoplasm, indicative of an impaired Hippo pathway, would be more susceptible to TEAD inhibition. This would provide a useful biomarker to identify cancer cell lines most likely to respond to TEAD inhibition. We therefore developed and validated an automated quantification method to score nuclear:cytoplasmic YAP/TAZ localization in melanoma cell lines. This enabled us to identify “Hippo-On” and “Hippo-Off” signatures. We then treated these lines with the TEAD inhibitor MGH-CP1 and performed cell viability assays. Results from these data demonstrated that cell lines that have greater nuclear localization of YAP/TAZ are more susceptible to MGH-CP1 inhibition, suggesting that YAP/TAZ nuclear localization may be a biomarker to identify candidates for TEAD inhibitor treatment.

The paralogous multi-functional adaptor proteins YAP and TAZ are nuclear effectors of the Hippo pathway, a central regulator of developmental organ size control, tissue homeostasis and tumour suppression. YAP/TAZ target the TEAD transcription factor family to promote cell survival and inhibit apoptosis. TEAD proteins contain a DNAbinding domain and a YAP/TAZ interaction domain. PCR analysis of medaka fish TEAD cDNA revealed the presence of alternative TEAD splice-forms with variations at the C-terminus of the DNA-binding domain. Structural analysis indicated the YAPbinding domain of TEAD proteins is folded and globular. NMR spectroscopy showed that the TEAD binding domain of YAP does not contain secondary structure. YAP and TAZ both contain WW domains, which are small protein-protein interaction modules. Two YAP isoforms are known, YAP1 and YAP2 that contain one and two WW domains, respectively. To date, only a single WW isoform of TAZ has been described. PCR analysis of medaka TAZ cDNA identified both single WW and tandem WW isoforms of TAZ. NMR spectroscopy was used to characterise structural, conformational, and peptide binding features of the tandem WW domains from YAP and TAZ. The YAP WW2 solution structure confirms that the domain has the canonical anti-parallel β-sheet WW fold. WW1 of YAP and both WW domains of TAZ undergo conformational exchange. The region linking the two WW domains is flexible and allows interaction of both WW domains with peptides containing single and dual PPxY binding motifs. In addition to YAP and TAZ, tandem WW domains are also present in the core and upstream Hippo pathway proteins Salvador and Kibra. Both proteins contain one atypical WW domain; the tandem WW domains of these two proteins are unstable. Understanding structure and function of Hippo pathway components could contribute to drug development and will also contribute to knowledge of protein folding and interactions.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第22641号 / 医博第4624号 / 新制||医||1044(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 山下 潤, 教授 湊谷 謙司, 教授 江藤 浩之 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

L'ovulation est le processus de rupture du follicule ovarien qui conduit à la libération d'un ovocyte dans l'oviducte pour la fécondation. Le processus ovulatoire est initié par un pic de LH qui conduit à l'activation du récepteur EGF (EGFR) dans les cellules de la granulosa (CG) qui stimule par conséquent l'expression de plusieurs gènes pré-ovulatoires essentiels. Environ 15% de l'infertilité chez les vaches est due à la présence de kystes ovariens qui se développent normalement à partir de follicules pré-ovulatoires qui n'ovulent pas. Chez les femmes et les rongeurs, alors que l'activité physiologique des effecteurs de signalisation Hippo semble essentielle pour la signalisation de l'EGF dans les CG, leur dérégulation peut jouer un rôle important dans les troubles kystiques anovulatoires. À notre connaissance, aucune étude n'a rapporté les rôles physiologiques ou physiopathologiques des effecteurs de la voie Hippo liés à l'ovulation ou à la formation de kystes ovariens chez les bovins. Les principaux objectifs de la présente thèse étaient donc (1) d'élucider l'importance de l'activité physiologique des effecteurs de signalisation Hippo dans la cascade pré-ovulatoire et dans l'ovulation chez les ruminants, et (2) de déterminer si la dérégulation de YAP dans le CG bovin est impliquée dans la pathogenèse de la maladie kystique des ovaires (MKO). Les résultats sont séparés en 2 articles. Dans le premier article, nous avons d'abord utilisé un système de culture de CG préovulatoire bien défini pour montrer que la signalisation YAP est essentielle pour l'expression de l'EGFR et des gènes cibles en aval EREG, EGR1 et TNFAIP6. Plus important encore, en utilisant un système d'injection folliculaire guidée par ultrasons, nous avons également montré que l'inhibiteur classique de la signalisation Hippo, la vertéporfine, inhibe l'ovulation induite par la GnRH in vivo chez les bovins. Dans le deuxième article, nous avons utilisé un modèle bovin de MKO spontanée pour montrer que l'abondance de l'ARNm et des protéines de YAP est significativement plus élevée dans les cellules de la granulosa et de la thèque (CT) isolées des follicules kystiques (structures folliculaires d'au moins 20 mm de diamètre) par rapport aux types de cellules respectifs isolés à partir de grands follicules non kystiques (≥12 mm). De plus, le schéma de phosphorylation de YAP et l'abondance accrue d'ARNm codant pour les gènes cibles YAP-TEAD classiques suggèrent que l'activité transcriptionnelle de YAP est augmentée dans les CG des kystes folliculaires par rapport aux grands follicules non kystiques. Ensemble, ces résultats montrent pour la première fois que la voie Hippo est essentielle à la cascade ovulatoire chez les bovins et que sa dérégulation peut jouer un rôle clé dans la pathogenèse de la maladie kystique des ovaires chez cette espèce. / Ovulation is the process of rupture of the ovarian follicle, which leads to the release of an oocyte into the oviduct for fertilization. The ovulatory process is initiated by a surge of LH that leads to the activation of the EGF receptor (EGFR) in granulosa cells (GC) which consequently stimulates the expression of several essential ovulatory genes. About 15% of infertility in cows is due to the presence of ovarian cysts that generally develop from pre-ovulatory follicles that fail to ovulate. In women and rodents, in addition to the essential physiological activity of Hippo signalling effectors for the EGF signalling in GC, their deregulation also plays an important role in anovulatory cystic disorders. To the best of our knowledge, no studies report physiological or pathophysiological roles of Hippo pathway effectors related to ovulation or ovarian cyst formation in cattle. The main objectives of the present thesis were, therefore, (1) to elucidate the importance of the physiological activity of Hippo signaling effectors in the pre-ovulatory cascade and in ovulation in ruminants and (2) to determine whether dysregulation of YAP in bovine GC is implicated in the pathogenesis of the cystic ovarian disease (COD). The results are separated into 2 articles. In the first article, we employed a well-defined preovulatory GC culture system to show that YAP signaling is essential for expressing EGFR and the downstream target genes EREG, EGR1 and TNFAIP6. Most importantly, using an ultrasound-guided follicular injection system, we have also shown that the classic Hippo signaling inhibitor verteporfin inhibits GnRH-induced ovulation in vivo in cattle. In the second article, we employed a bovine model of spontaneous COD to show that YAP mRNA and protein abundance are significantly higher in granulosa and theca (TC) cells isolated from cystic follicles (follicular structures of at least 20 mm in diameter) compared to the respective cell types isolated from large non-cystic follicles (≥12 mm). Moreover, the phosphorylation pattern of YAP and the increased abundance of mRNA encoding classical YAP-TEAD target genes suggest that the transcriptional activity of YAP is increased in GC of follicular cysts compared to large non-cystic follicles. Together, these results show for the first time that the Hippo pathway is critical to the ovulatory cascade in cattle and its dysregulation may play a key role in the pathogenesis of cystic ovarian disease in this species.